NTT-COMMUNICATIONS
27.3.2024 01:01:32 CET | Business Wire | Press release
NTT Communications Corporation (NTT Com) and the Hokuriku Regional Office of NTT DOCOMO, INC. (DOCOMO), together with the city of Kanazawa, celebrated the opening of a new section of the Hokuriku Shinkansen Line between Kanazawa and Tsuruga by holding digital events on March 16 under the theme of "Connection," a key component of NTT Group’s Innovative Optical and Wireless Network (IOWN) concept.1
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240325762257/en/
Scheme of live remote performance (Graphic: Business Wire)
The events included a live remote performance that seamlessly connected musicians in Kanazawa and Tokyo, a distance of about 1,000 kilometers, via the All-Photonics Network (APN). For the connection, NTT Com provided its APN Leased Line Plan powered by IOWN,2 which used the longest optical cable ever deployed in an IOWN demonstration and the first to be deployed in Japan's Hokuriku region.
The event brought together the Kanazawa Junior Jazz Orchestra JAZZ-21, consisting mainly of middle and high school students who have performed at the areas affected by the Great East Japan Earthquake and various major festivals around the world, and celebrated violinist Mayu Kijima, winner of numerous international competitions, including the 1st Shanghai Isaac Stern International Violin Competition in 2016, who performed with the Walner violin made by Antonio Stradivari 1699, which was on loan from the Munetsugu Collection.
Kanazawa City provided the demonstration environment and operated the venue in its area and NTT Com provided the APN transmission equipment and the venue in Tokyo. NTT Com and DOCOMO livestreamed the event on Kanazawa's metaverse platform using DOCOMO's 5G video transmission system, allowing viewers at home to enjoy the live event on PCs, smartphones and tablets via the browser-based virtual space platform DOOR.3 In addition, DOCOMO used its Hide Mode4 function to allow more people than normal to enter the virtual room. This was the first time in Japan that a metaverse space open to the public was used for a music event.
In another demonstration, smart lighting was used to allow spectators to digitally interact with Kanazawa's famous Tsuzumi-mon Gate to influence its illumination on the evening of March 16. Using 5G communication and IoT technology, spectators were able change the illumination by selecting from eight patterns via tablets placed near the gate. The demonstration, called “Connecting with Tsuzumi-mon Gate,” allowed people to make a special connection with the iconic site, including to take commemorative photos.
A third commemorative demonstration on March 16, called “Connecting with Other Locations,” allowed visitors to the Underground Plaza of the Motenashi Dome near Kanazawa Station to view and experience famous scenes along the Hokuriku Shinkansen line via a wide-angle virtual reality display without the use of goggles. During the demonstration, multiple people simultaneously enjoyed videos, 360-degree images and metaverse spaces, and even the experience of sitting in a Shinkansen driver's seat while traveling on the newly extended Hokuriku Shinkansen line.
DOCOMO group, under an agreement signed with the city of Kanazawa and West Japan Railway Company in 2019, is working to promote local attractions using 5G and other advanced technologies. Following the recent Noto Peninsula Earthquake on January 1, DOCOMO has strengthened its efforts to work with the people of the Hokuriku region to revitalize the region and support its recovery and reconstruction. Going forward, based on the lessons learned from the event to commemorate the Hokuriku Shinkansen Line's extension, NTT Com and DOCOMO are committed to providing new value to Kanazawa citizens and customers by incorporating new technologies, including the IOWN APN where possible, to promote the attractiveness of Kanazawa and contribute to the revitalization of the region.
1 Network infrastructure concept for creating an enriched society using advanced optical technologies, etc. IOWN® is a trademark of NTT Corporation. https://www.rd.ntt/e/iown/
2 NTT Com began offering APN communication services spanning prefectures from March 1 to meet customers' needs for advanced communication infrastructure.
3 DOCOMO's subsidiary NTT QONOQ INC. (https://www.nttqonoq.com/?lang=en) provides this service for holding events and displaying content in virtual spaces.
4 While 24 people is the normal recommended capacity of a virtual room, Hide Mode is a paid option that allows hundreds of people to enter, with certain limited capabilities. Please visit https://door.ntt/web/faq/index.html.
About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, the world's most advanced data-center facilities (more than 500,000m2) and cutting-edge technologies for cloud, security and AI. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities, leveraging 5G, IoT and other technologies under the "docomo business" brand. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com
About NTT DOCOMO
NTT DOCOMO, Japan’s leading mobile operator with over 89 million subscriptions, is one of the world’s foremost contributors to 3G, 4G and 5G mobile network technologies. Beyond core communications services, DOCOMO is challenging new frontiers in collaboration with a growing number of entities ("+d" partners), creating exciting and convenient value-added services that change the way people live and work. Under a medium-term plan toward 2020 and beyond, DOCOMO is pioneering a leading-edge 5G network to facilitate innovative services that will amaze and inspire customers beyond their expectations.
https://www.docomo.ne.jp/english/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240325762257/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom